- £704.66m
- £616.92m
- €69.97m
- 96
- 45
- 35
- 62
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 3.28 | 125 | 108 | 68 | 32.8 |
Net Total Receivables | 2.27 | 1.34 | 35 | 2.13 | 4.76 |
Total Other Current Assets | |||||
Total Current Assets | 5.55 | 126 | 143 | 70.1 | 106 |
Long Term Investments | |||||
Total Assets | 1,117 | 1,234 | 1,493 | 1,311 | 1,307 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 17.8 | 32.4 | 2.84 | 11.9 | 13 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 17.8 | 32.4 | 2.84 | 11.9 | 13 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 1,099 | 1,201 | 1,490 | 1,299 | 1,294 |
Total Liabilities & Shareholders' Equity | 1,117 | 1,234 | 1,493 | 1,311 | 1,307 |
Total Common Shares Outstanding |